Literature DB >> 18332018

Two to five year follow-up of the LPM ceramic coated proximal interphalangeal joint arthroplasty.

J Field1.   

Abstract

This paper presents a retrospective series of 20 LPM semi-constrained ceramic coated cobalt chrome proximal interphalangeal joint arthroplasties performed consecutively in 12 patients for arthritis of the proximal interphalangeal joint by a single surgeon between 2000 and 2004. Eleven were performed for osteoarthritis, four for post-traumatic arthritis and five for rheumatoid arthritis. Although 12 joints had an improvement in pain and an increased functional arc of movement, six joints required revision surgery for implant failure at an average of 19 months, with clinical signs of increasing pain, deteriorating motion and radiological signs of implant loosening and subsidence. This rate of revision is higher than in published series for other PIP joint implants and, therefore, close surveillance of all patients with this prosthesis currently in situ is recommended. Use of the prosthesis has ceased in this unit.

Entities:  

Mesh:

Year:  2008        PMID: 18332018     DOI: 10.1177/1753193407087864

Source DB:  PubMed          Journal:  J Hand Surg Eur Vol        ISSN: 0266-7681


  4 in total

Review 1.  Topical therapies for osteoarthritis.

Authors:  Roy D Altman; H Richard Barthel
Journal:  Drugs       Date:  2011-07-09       Impact factor: 9.546

Review 2.  Pharmacological therapies for osteoarthritis of the hand: a review of the evidence.

Authors:  Roy D Altman
Journal:  Drugs Aging       Date:  2010-09-01       Impact factor: 3.923

3.  Duloxetine in the management of chronic musculoskeletal pain.

Authors:  Howard S Smith; Eric J Smith; Benjamin R Smith
Journal:  Ther Clin Risk Manag       Date:  2012-06-19       Impact factor: 2.423

4.  Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis.

Authors:  H Richard Barthel; John H Peniston; Michael B Clark; Morris S Gold; Roy D Altman
Journal:  Arthritis Res Ther       Date:  2010-01-11       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.